Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma
We report a case of tumor lysis syndrome (TLS) occurring 48 h after initiation of targeted therapy with Encorafénib and Binimétinib in a patient with an extensive metastatic melanoma harboring a BRAF V600E mutation. The patient required intensive care management, including systemic treatment with an...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2026-01-01
|
| Seri Bilgileri: | EJC Skin Cancer |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2772611826000029 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|